Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Hauser RA
This product is intended exclusively for qualified researchers operating within approved protocols and appropriate biosafety frameworks
Open questions How can we optimize the specificity of ROS-targeted agents for application across various cancer contexts, thereby improving precision in cancer treatment
doi: 10.1007/s00404-024-07843-1 206 LowryD
Study records: PCO-02 safety and pharmacokinetics trial, Pentadecapeptide BPC 157 for Acute Grade II Hamstring Strain (NCT07437547), Intra-articular injection of BPC 157 for multiple types of knee pain, Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study, Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review, A new gastric juice peptide, BPC, and characterization of its 15 amino acid fragment BPC 157, BPC-157 protection against gastric and duodenal lesions in rat ulcer models Evidence boundary: These records do not test the vial, capsule, nasal-spray, and topical formats observed in the research-use market, and the preclinical findings do not establish human efficacy for any indication
US$ 24.98
US$ 20.04
-1.jpg&w=1200&q=75)
US$ 28.04
US$ 22.18
US$ 24.25
